Health ❯ Healthcare ❯ Treatment Options

Medications

Eye Drops Dupilumab SMA Treatments Hydroxyurea Supportive Care Antifibrotic Medications PDE4 Inhibitors Glucocorticoids Laser Therapies Hormone Replacement Therapy Topical Steroids IBS Treatments Anti-Amyloid Drugs Botulinum Toxin Biologics Surgery Levodopa Lipid-Lowering Drugs GLP-1 Agonists Lecanemab Omalizumab Benralizumab Neuromodulation Pain Relief Symptom Management Monoclonal Antibodies Aldosterone Blockers Anticoagulants Alzheimer's Treatment SSRIs COVID-19 Pills Alternative Treatments Ocrelizumab Immunotherapies Corticosteroids

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

CHMP's positive opinion advances the drug toward EU marketing authorisation with national decisions set to determine patient access and payment

NYU Study Finds Highest Sickle Cell Death Risk and Costs on Long Island

EMA Panel Recommends Redemplo for Familial Chylomicronaemia Syndrome

AGA Overhauls Crohn’s Treatment With Living Guideline Favoring Early High‑Efficacy Therapies

AGA Survey Shows IBS Cuts Into Work and Social Activities Nearly 20 Days Each Month